102 Conversely, numerous teams are advocating for your incorporation of novel markers, like a complicated karyotype55 or epigenetic subsets, 27,28 into medical practice. Each one of these novel prognostic and/or predictive styles will need to be validated in cohorts of clients treated with focused b